BHV-1440
/ Biohaven
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 10, 2026
BHV-1440: Novel TRAP(TM) Degrader for the Treatment of Graves' Disease Selectively Removes Tshr Autoantibodies from Circulation and Thyroid Tissue, Restoring Normal Thyroid Function in Preclinical Models of Graves' Disease.
(ATA 2026)
- No abstract available
Preclinical • Endocrine Disorders • Grave’s Disease
1 to 1
Of
1
Go to page
1